Author:
Boomershine Chad S.,Crofford Leslie J.
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Wolfe, F., Ross, K., Anderson, J., Russell, I. J. & Hebert, L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 38, 19–28 (1995).
2. Wolfe, F. & Michaud, K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J. Rheumatol. 31, 695–700 (2004).
3. Middleton, G. D., McFarlin, J. E. & Lipsky, P. E. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum. 37, 1181–1188 (1994).
4. Berenson, A. Drug approved. Is disease real? (online 14 January 2008) [
http://www.nytimes.com/2008/01/14/health/14pain.html
] (accessed 29 September 2008).
5. Carville, S. F. et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann. Rheum. Dis. 67, 536–541 (2008).